Many organizations still watch from the sidelines as competitors transform their understanding of data with AI. Why is this?
3 min read
2 min read
By engaging with the right medical experts as early as possible in a drug’s lifecycle, pharmaceutical companies can gain enduring competitive edge. However, despite medical affairs departments continually undergoing profound change and growth, studies show 50% of new drug launches fail to meet company expectations. Could embracing AI in life sciences help to tackle this trend?